SlideShare a Scribd company logo
How will the academy
       engage stakeholders?
           Ingrid Klingmann, Chairman,
European Forum For Good Clinical Practice, Belgium
EUPATI grows a pan-European
network involving all stakeholders
   builds a unique, pan-European, intellectual pool and
    dissemination multiplicator

   optimises the platform for communication and programme
    awareness

   provides the expertise and support to EUPATI and beyond
Network supported by powerful
infrastructure



                          Liaison Teams
  WP2 Coordination
                       Digital communication
  Annual Conferences         platform for
                         network members
 Regional Workshops
                       EUPATI Ethics Panel
Identifying key stakeholders
of EUPATI

                                             Regulatory                Health-
                                             authorities               related
                                                                        NGOs
                                Research
      Academia                  networks,
                                & projects

                   Industry &
                     CROs
       Patient                                             Policy
      Advocacy                                             makers
        Orgs                                                (EU &
      (national/                                           Member
        int‘l)                                             States)    Journa-
                    Ethics
                     Com-                                                lists
                    mittees                                          (medical, la
                                                                       y press)
Inviting EUPATI stakeholder groups
to join the “EUPATI Network”
   Get connected on the Internet
    • Info about EUPATI – Newsletter,
      Facebook, Twitter, LinkedIn, Google+
    • Invitation to proactively join the Network
    • Get recommendations on pre-existing
      educational material
   Regional Meeting, 09/2012, Frankfurt,
    engaging experienced Patient Organisation representatives
   EUPATI Annual Conference, Q1/2013
   Present EUPATI at medical, scientific and advocacy conferences
    across EU
     • Speakers of EUPATI consortium
     • Translation of EUPATI presentations in 7 languages
Developing
National EUPATI Platforms
   Establishment of patient-led national platforms in
    EUPATI countries, initiated by one representative each:
     • Patient Organisation, Academia, Industry
   EUPATI will support trios to identify best national approach on
    establishment National Platforms
     • Topics, material, meeting infrastructure, information dissemination,
       event advertisement
   Use of EUPATI network,
    Social Media,
    EUPATI digital platform
     • Information about EUPATI
     • Invitation to join activities
Your ideas are very welcome!
          Discussion
Get to know us!




                  Web:
                  www.patientsacademy.eu

                  Twitter: @eupatients
                  as well as:

More Related Content

What's hot

UK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development PlanUK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development Plan
David Wortley
 
Improving access to medicines in Uganda
Improving access to medicines in UgandaImproving access to medicines in Uganda
Improving access to medicines in Uganda
MeTApresents
 
Unite-IT: Setting the Scene
Unite-IT: Setting the SceneUnite-IT: Setting the Scene
Unite-IT: Setting the Scene
TELECENTRE EUROPE
 
Holistic view on inclusive lifelong learning
Holistic view on inclusive lifelong learningHolistic view on inclusive lifelong learning
Holistic view on inclusive lifelong learning
Karel Van Isacker
 
Kurt Zatloukal
Kurt ZatloukalKurt Zatloukal
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"
EURORDIS - Rare Diseases Europe
 
CAMS GA Communication activities
CAMS GA Communication activitiesCAMS GA Communication activities
CAMS GA Communication activities
Copernicus ECMWF
 
Open source workshop, MIE2009
Open source workshop, MIE2009Open source workshop, MIE2009
Open source workshop, MIE2009
Peter Murray
 
Pnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancis
Pnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancisPnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancis
Pnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancis
Technical Centre for Agricultural and Rural Cooperation ACP-EU (CTA)
 
Spots and Announcement in Health Education
Spots and Announcement  in Health EducationSpots and Announcement  in Health Education
Spots and Announcement in Health Education
Govinda Rokka
 
Data protection ownership and portability a code of conduct for mHealth apps
Data protection ownership and portability a code of conduct for mHealth apps Data protection ownership and portability a code of conduct for mHealth apps
Data protection ownership and portability a code of conduct for mHealth apps
3GDR
 
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal PathwaysBioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
Lisette Giepmans
 
The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...
The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...
The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...
Environmental Protection Agency, Ireland
 
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvisTue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
3GDR
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
EURORDIS - Rare Diseases Europe
 
SCA IPR Toolkit
SCA IPR ToolkitSCA IPR Toolkit
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
patvocates
 
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
DRIVE research
 
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
patvocates
 

What's hot (20)

UK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development PlanUK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development Plan
 
Improving access to medicines in Uganda
Improving access to medicines in UgandaImproving access to medicines in Uganda
Improving access to medicines in Uganda
 
Unite-IT: Setting the Scene
Unite-IT: Setting the SceneUnite-IT: Setting the Scene
Unite-IT: Setting the Scene
 
Holistic view on inclusive lifelong learning
Holistic view on inclusive lifelong learningHolistic view on inclusive lifelong learning
Holistic view on inclusive lifelong learning
 
Kurt Zatloukal
Kurt ZatloukalKurt Zatloukal
Kurt Zatloukal
 
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"
 
CAMS GA Communication activities
CAMS GA Communication activitiesCAMS GA Communication activities
CAMS GA Communication activities
 
Open source workshop, MIE2009
Open source workshop, MIE2009Open source workshop, MIE2009
Open source workshop, MIE2009
 
Pnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancis
Pnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancisPnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancis
Pnp png workshop2016_paceu fnssa cooperation_innovation niches_cta_jfrancis
 
Spots and Announcement in Health Education
Spots and Announcement  in Health EducationSpots and Announcement  in Health Education
Spots and Announcement in Health Education
 
Data protection ownership and portability a code of conduct for mHealth apps
Data protection ownership and portability a code of conduct for mHealth apps Data protection ownership and portability a code of conduct for mHealth apps
Data protection ownership and portability a code of conduct for mHealth apps
 
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal PathwaysBioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
 
The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...
The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...
The European Climate Change Adaptation Platform: CLIMATE-ADAPT - Dr. Margaret...
 
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvisTue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
SCA IPR Toolkit
SCA IPR ToolkitSCA IPR Toolkit
SCA IPR Toolkit
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
 
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
 
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...The patient voice: turning health policy into opportunity - Jan Geissler - ES...
The patient voice: turning health policy into opportunity - Jan Geissler - ES...
 

Similar to EUPATI Launch Meeting - Klingmann

Jornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas BereczkyJornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas Bereczky
Instituto Aragonés de Ciencias de la Salud - IACS
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
jangeissler
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
jangeissler
 
ISPOR Eupati meeting - Dr Derick Mitchell - November 2017
ISPOR Eupati meeting - Dr Derick Mitchell - November 2017ISPOR Eupati meeting - Dr Derick Mitchell - November 2017
ISPOR Eupati meeting - Dr Derick Mitchell - November 2017
ipposi
 
Beni Gómez - APTIC a knowledge repository for parents and caregivers of chil...
Beni Gómez  - APTIC a knowledge repository for parents and caregivers of chil...Beni Gómez  - APTIC a knowledge repository for parents and caregivers of chil...
Beni Gómez - APTIC a knowledge repository for parents and caregivers of chil...
WTHS
 
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMIPistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance
 
AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)
AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)
AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)
AEGIS-ACCESSIBLE Projects
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI
 
Assistive Technology Learning Through A Unified Curriculum
Assistive Technology Learning Through A Unified CurriculumAssistive Technology Learning Through A Unified Curriculum
Assistive Technology Learning Through A Unified Curriculum
Karel Van Isacker
 
EU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveEU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspective
ipposi
 
EUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategyEUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategy
EUnetHTA
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
ipposi
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe
ipposi
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
jangeissler
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
ipposi
 
The Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health CommunicationThe Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health Communication
Plan de Calidad para el SNS
 
H2020 ICT and Health Webinar - Samana Brannigan, Innovate UK
H2020 ICT and Health Webinar - Samana Brannigan, Innovate UKH2020 ICT and Health Webinar - Samana Brannigan, Innovate UK
H2020 ICT and Health Webinar - Samana Brannigan, Innovate UK
KTN
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2
EUPATI
 
Boosting drug development through public private partnerships (Laverty OECD P...
Boosting drug development through public private partnerships (Laverty OECD P...Boosting drug development through public private partnerships (Laverty OECD P...
Boosting drug development through public private partnerships (Laverty OECD P...
Per Koch
 

Similar to EUPATI Launch Meeting - Klingmann (20)

Jornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas BereczkyJornadas #PatientInHTA · Tamas Bereczky
Jornadas #PatientInHTA · Tamas Bereczky
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
ISPOR Eupati meeting - Dr Derick Mitchell - November 2017
ISPOR Eupati meeting - Dr Derick Mitchell - November 2017ISPOR Eupati meeting - Dr Derick Mitchell - November 2017
ISPOR Eupati meeting - Dr Derick Mitchell - November 2017
 
Beni Gómez - APTIC a knowledge repository for parents and caregivers of chil...
Beni Gómez  - APTIC a knowledge repository for parents and caregivers of chil...Beni Gómez  - APTIC a knowledge repository for parents and caregivers of chil...
Beni Gómez - APTIC a knowledge repository for parents and caregivers of chil...
 
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMIPistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
 
AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)
AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)
AEGIS presentation at DRT4ALL (by Karel Van Isacker - EPR)
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
 
Assistive Technology Learning Through A Unified Curriculum
Assistive Technology Learning Through A Unified CurriculumAssistive Technology Learning Through A Unified Curriculum
Assistive Technology Learning Through A Unified Curriculum
 
EU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspectiveEU Clinical Trials Regulation - IPPOSI perspective
EU Clinical Trials Regulation - IPPOSI perspective
 
EUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategyEUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategy
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
 
EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017EPIS meeting - Dr Derick Mitchell - October 2017
EPIS meeting - Dr Derick Mitchell - October 2017
 
The Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health CommunicationThe Role of Portals and Blogs in Health Communication
The Role of Portals and Blogs in Health Communication
 
H2020 ICT and Health Webinar - Samana Brannigan, Innovate UK
H2020 ICT and Health Webinar - Samana Brannigan, Innovate UKH2020 ICT and Health Webinar - Samana Brannigan, Innovate UK
H2020 ICT and Health Webinar - Samana Brannigan, Innovate UK
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2
 
Boosting drug development through public private partnerships (Laverty OECD P...
Boosting drug development through public private partnerships (Laverty OECD P...Boosting drug development through public private partnerships (Laverty OECD P...
Boosting drug development through public private partnerships (Laverty OECD P...
 

More from jangeissler

Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
jangeissler
 
Don't just talk about patient centricity - put meaningful patient engagement ...
Don't just talk about patient centricity - put meaningful patient engagement ...Don't just talk about patient centricity - put meaningful patient engagement ...
Don't just talk about patient centricity - put meaningful patient engagement ...
jangeissler
 
CML: A tiger in the cage? A (European) perspective on CML disease management
CML: A tiger in the cage? A (European) perspective on CML disease managementCML: A tiger in the cage? A (European) perspective on CML disease management
CML: A tiger in the cage? A (European) perspective on CML disease management
jangeissler
 
Sicht der Patienten auf Real World Data, Register und Versorgungsdaten
Sicht der Patienten auf Real World Data, Register und VersorgungsdatenSicht der Patienten auf Real World Data, Register und Versorgungsdaten
Sicht der Patienten auf Real World Data, Register und Versorgungsdaten
jangeissler
 
Überblick der Aktivitäten von Leukämie-Online und CML Advocates Network
Überblick der Aktivitäten von Leukämie-Online und CML Advocates NetworkÜberblick der Aktivitäten von Leukämie-Online und CML Advocates Network
Überblick der Aktivitäten von Leukämie-Online und CML Advocates Network
jangeissler
 
Andreas Willer - Rehabilitation für Patienten mit CML
Andreas Willer - Rehabilitation für Patienten mit CMLAndreas Willer - Rehabilitation für Patienten mit CML
Andreas Willer - Rehabilitation für Patienten mit CML
jangeissler
 
Umfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
Umfrage zur Therapiefreien Remission (TFR) der CML-PatientengemeinschaftUmfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
Umfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
jangeissler
 
Patientenperspektive im Studiendesign
Patientenperspektive im Studiendesign Patientenperspektive im Studiendesign
Patientenperspektive im Studiendesign
jangeissler
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
 
Reasonable Legal Agreements between Patient Advocates and Pharma Companies
Reasonable Legal Agreements between Patient Advocates and Pharma CompaniesReasonable Legal Agreements between Patient Advocates and Pharma Companies
Reasonable Legal Agreements between Patient Advocates and Pharma Companies
jangeissler
 
Bericht LeukaNET / leukaemie-online.de und CML Advocates Network
Bericht LeukaNET / leukaemie-online.de und CML Advocates NetworkBericht LeukaNET / leukaemie-online.de und CML Advocates Network
Bericht LeukaNET / leukaemie-online.de und CML Advocates Network
jangeissler
 
How to get the most of the EHA congress as a CML patient advocate
How to get the most of the EHA congress as a CML patient advocateHow to get the most of the EHA congress as a CML patient advocate
How to get the most of the EHA congress as a CML patient advocate
jangeissler
 
European Patient Perspective on Access and Innovation with Multiplex Genomic ...
European Patient Perspective on Access and Innovation with Multiplex Genomic ...European Patient Perspective on Access and Innovation with Multiplex Genomic ...
European Patient Perspective on Access and Innovation with Multiplex Genomic ...
jangeissler
 
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
jangeissler
 
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
jangeissler
 
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
jangeissler
 
How to get the most of EHA as a patient advocate
How to get the most of EHA as a patient advocateHow to get the most of EHA as a patient advocate
How to get the most of EHA as a patient advocate
jangeissler
 
PCR-Info-Projekt (Cornelia Borowczak)
PCR-Info-Projekt (Cornelia Borowczak)PCR-Info-Projekt (Cornelia Borowczak)
PCR-Info-Projekt (Cornelia Borowczak)
jangeissler
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
jangeissler
 

More from jangeissler (20)

Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
 
Don't just talk about patient centricity - put meaningful patient engagement ...
Don't just talk about patient centricity - put meaningful patient engagement ...Don't just talk about patient centricity - put meaningful patient engagement ...
Don't just talk about patient centricity - put meaningful patient engagement ...
 
CML: A tiger in the cage? A (European) perspective on CML disease management
CML: A tiger in the cage? A (European) perspective on CML disease managementCML: A tiger in the cage? A (European) perspective on CML disease management
CML: A tiger in the cage? A (European) perspective on CML disease management
 
Sicht der Patienten auf Real World Data, Register und Versorgungsdaten
Sicht der Patienten auf Real World Data, Register und VersorgungsdatenSicht der Patienten auf Real World Data, Register und Versorgungsdaten
Sicht der Patienten auf Real World Data, Register und Versorgungsdaten
 
Überblick der Aktivitäten von Leukämie-Online und CML Advocates Network
Überblick der Aktivitäten von Leukämie-Online und CML Advocates NetworkÜberblick der Aktivitäten von Leukämie-Online und CML Advocates Network
Überblick der Aktivitäten von Leukämie-Online und CML Advocates Network
 
Andreas Willer - Rehabilitation für Patienten mit CML
Andreas Willer - Rehabilitation für Patienten mit CMLAndreas Willer - Rehabilitation für Patienten mit CML
Andreas Willer - Rehabilitation für Patienten mit CML
 
Umfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
Umfrage zur Therapiefreien Remission (TFR) der CML-PatientengemeinschaftUmfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
Umfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
 
Patientenperspektive im Studiendesign
Patientenperspektive im Studiendesign Patientenperspektive im Studiendesign
Patientenperspektive im Studiendesign
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
Reasonable Legal Agreements between Patient Advocates and Pharma Companies
Reasonable Legal Agreements between Patient Advocates and Pharma CompaniesReasonable Legal Agreements between Patient Advocates and Pharma Companies
Reasonable Legal Agreements between Patient Advocates and Pharma Companies
 
Bericht LeukaNET / leukaemie-online.de und CML Advocates Network
Bericht LeukaNET / leukaemie-online.de und CML Advocates NetworkBericht LeukaNET / leukaemie-online.de und CML Advocates Network
Bericht LeukaNET / leukaemie-online.de und CML Advocates Network
 
How to get the most of the EHA congress as a CML patient advocate
How to get the most of the EHA congress as a CML patient advocateHow to get the most of the EHA congress as a CML patient advocate
How to get the most of the EHA congress as a CML patient advocate
 
European Patient Perspective on Access and Innovation with Multiplex Genomic ...
European Patient Perspective on Access and Innovation with Multiplex Genomic ...European Patient Perspective on Access and Innovation with Multiplex Genomic ...
European Patient Perspective on Access and Innovation with Multiplex Genomic ...
 
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
 
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
 
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
 
How to get the most of EHA as a patient advocate
How to get the most of EHA as a patient advocateHow to get the most of EHA as a patient advocate
How to get the most of EHA as a patient advocate
 
PCR-Info-Projekt (Cornelia Borowczak)
PCR-Info-Projekt (Cornelia Borowczak)PCR-Info-Projekt (Cornelia Borowczak)
PCR-Info-Projekt (Cornelia Borowczak)
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
 

Recently uploaded

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

EUPATI Launch Meeting - Klingmann

  • 1. How will the academy engage stakeholders? Ingrid Klingmann, Chairman, European Forum For Good Clinical Practice, Belgium
  • 2. EUPATI grows a pan-European network involving all stakeholders  builds a unique, pan-European, intellectual pool and dissemination multiplicator  optimises the platform for communication and programme awareness  provides the expertise and support to EUPATI and beyond
  • 3. Network supported by powerful infrastructure Liaison Teams WP2 Coordination Digital communication Annual Conferences platform for network members Regional Workshops EUPATI Ethics Panel
  • 4. Identifying key stakeholders of EUPATI Regulatory Health- authorities related NGOs Research Academia networks, & projects Industry & CROs Patient Policy Advocacy makers Orgs (EU & (national/ Member int‘l) States) Journa- Ethics Com- lists mittees (medical, la y press)
  • 5. Inviting EUPATI stakeholder groups to join the “EUPATI Network”  Get connected on the Internet • Info about EUPATI – Newsletter, Facebook, Twitter, LinkedIn, Google+ • Invitation to proactively join the Network • Get recommendations on pre-existing educational material  Regional Meeting, 09/2012, Frankfurt, engaging experienced Patient Organisation representatives  EUPATI Annual Conference, Q1/2013  Present EUPATI at medical, scientific and advocacy conferences across EU • Speakers of EUPATI consortium • Translation of EUPATI presentations in 7 languages
  • 6. Developing National EUPATI Platforms  Establishment of patient-led national platforms in EUPATI countries, initiated by one representative each: • Patient Organisation, Academia, Industry  EUPATI will support trios to identify best national approach on establishment National Platforms • Topics, material, meeting infrastructure, information dissemination, event advertisement  Use of EUPATI network, Social Media, EUPATI digital platform • Information about EUPATI • Invitation to join activities
  • 7. Your ideas are very welcome! Discussion
  • 8. Get to know us! Web: www.patientsacademy.eu Twitter: @eupatients as well as: